PAVmed Inc (PAVMZ)
USD 0.02
(32.0%)
USD 0.02
(32.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 57.13 Million USD | 32.73% |
| 2022 | 43.04 Million USD | 469.54% |
| 2021 | 7.55 Million USD | -62.68% |
| 2020 | 20.25 Million USD | 70.48% |
| 2019 | 11.87 Million USD | 8.26% |
| 2018 | 10.97 Million USD | 144.49% |
| 2017 | 4.48 Million USD | 277.31% |
| 2016 | 1.18 Million USD | 105.02% |
| 2015 | 580.17 Thousand USD | 1127.9% |
| 2014 | 47.24 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 57.82 Million USD | 1.21% |
| 2024 Q2 | 58.05 Million USD | 0.39% |
| 2023 Q1 | 54.48 Million USD | 26.57% |
| 2023 FY | 57.13 Million USD | 32.73% |
| 2023 Q4 | 57.13 Million USD | -1.23% |
| 2023 Q3 | 57.84 Million USD | 6.12% |
| 2023 Q2 | 54.51 Million USD | 0.06% |
| 2022 Q4 | 43.04 Million USD | -1.97% |
| 2022 Q2 | 41.05 Million USD | 109.43% |
| 2022 Q1 | 19.6 Million USD | 159.34% |
| 2022 FY | 43.04 Million USD | 469.54% |
| 2022 Q3 | 43.9 Million USD | 6.96% |
| 2021 Q1 | 3.32 Million USD | -83.56% |
| 2021 FY | 7.55 Million USD | -62.68% |
| 2021 Q2 | 5.33 Million USD | 60.14% |
| 2021 Q4 | 7.55 Million USD | -2.49% |
| 2021 Q3 | 7.75 Million USD | 45.39% |
| 2020 Q1 | 26.34 Million USD | 121.76% |
| 2020 Q2 | 21.68 Million USD | -17.67% |
| 2020 Q3 | 25.26 Million USD | 16.5% |
| 2020 Q4 | 20.25 Million USD | -19.85% |
| 2020 FY | 20.25 Million USD | 70.48% |
| 2019 Q2 | 8.93 Million USD | -10.82% |
| 2019 Q1 | 10.02 Million USD | -8.64% |
| 2019 Q4 | 11.87 Million USD | 74.36% |
| 2019 Q3 | 6.81 Million USD | -23.79% |
| 2019 FY | 11.87 Million USD | 8.26% |
| 2018 Q3 | 5.83 Million USD | 23.74% |
| 2018 FY | 10.97 Million USD | 144.49% |
| 2018 Q4 | 10.97 Million USD | 88.06% |
| 2018 Q2 | 4.71 Million USD | 34.3% |
| 2018 Q1 | 3.51 Million USD | -21.77% |
| 2017 FY | 4.48 Million USD | 277.31% |
| 2017 Q2 | 5.27 Million USD | -2.44% |
| 2017 Q3 | 9.14 Million USD | 73.34% |
| 2017 Q4 | 4.48 Million USD | -50.93% |
| 2017 Q1 | 5.4 Million USD | 354.7% |
| 2016 Q2 | 403.32 Thousand USD | -52.23% |
| 2016 Q1 | 844.25 Thousand USD | 45.52% |
| 2016 Q4 | 1.18 Million USD | 41.23% |
| 2016 FY | 1.18 Million USD | 105.02% |
| 2016 Q3 | 842.23 Thousand USD | 108.82% |
| 2015 Q2 | 85.18 Thousand USD | 101.44% |
| 2015 Q3 | 238.51 Thousand USD | 179.99% |
| 2015 FY | 580.17 Thousand USD | 1127.9% |
| 2015 Q4 | 580.17 Thousand USD | 143.24% |
| 2015 Q1 | 42.29 Thousand USD | 0.0% |
| 2014 FY | 47.24 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | -4.19% |
| Axonics, Inc. | 82.35 Million USD | 30.624% |
| INVO Bioscience, Inc. | 19.99 Million USD | -185.757% |
| CVRx, Inc. | 39.28 Million USD | -45.453% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 74.383% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1695.664% |
| MaxCyte, Inc. | 36.1 Million USD | -58.244% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -165.902% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 53.909% |
| Sintx Technologies, Inc. | 6.59 Million USD | -766.631% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -11.478% |
| Apyx Medical Corporation | 52.31 Million USD | -9.211% |
| Cutera, Inc. | 518.12 Million USD | 88.972% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -969.581% |
| NeuroPace, Inc. | 86.99 Million USD | 34.323% |
| IRIDEX Corporation | 24.91 Million USD | -129.337% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 34.921% |
| enVVeno Medical Corporation | 2.43 Million USD | -2246.489% |
| TELA Bio, Inc. | 59.16 Million USD | 3.431% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 91.059% |
| UFP Technologies, Inc. | 118.04 Million USD | 51.597% |
| Modular Medical, Inc. | 2.27 Million USD | -2414.833% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -94.821% |
| LENSAR, Inc. | 22.4 Million USD | -154.973% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 97.396% |
| Surmodics, Inc. | 65.82 Million USD | 13.196% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -453.707% |
| Inogen, Inc. | 121.38 Million USD | 52.928% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -3313.202% |
| RxSight, Inc. | 22.18 Million USD | -157.513% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -13335.117% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -93.154% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -146.983% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -13335.117% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2251.994% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 45.378% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 91.878% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -124.392% |
| Dynatronics Corporation | 11.78 Million USD | -385.029% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -10.596% |
| InMode Ltd. | 75.91 Million USD | 24.735% |
| Bruker Corporation | 2.83 Billion USD | 97.986% |
| Movano Inc. | 5.97 Million USD | -856.748% |
| Orthofix Medical Inc. | 326.58 Million USD | 82.505% |
| FONAR Corporation | 57.45 Million USD | 0.558% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1119.573% |
| Envoy Medical, Inc. | 9.4 Million USD | -507.711% |
| Align Technology, Inc. | 2.45 Billion USD | 97.671% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 2.107% |
| Talis Biomedical Corporation | 29.22 Million USD | -95.514% |
| Cerus Corporation | 144.3 Million USD | 60.405% |
| 908 Devices Inc. | 37.49 Million USD | -52.406% |
| Nemaura Medical Inc. | 26.37 Million USD | -116.613% |
| Outset Medical, Inc. | 190.91 Million USD | 70.072% |
| NanoVibronix, Inc. | 2.68 Million USD | -2027.215% |
| Venus Concept Inc. | 107.1 Million USD | 46.652% |
| Telesis Bio, Inc. | 40.87 Million USD | -39.792% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 49.866% |
| Quipt Home Medical Corp. | 136.29 Million USD | 58.078% |
| IRadimed Corporation | 20.73 Million USD | -175.546% |
| Tenon Medical, Inc. | 5.56 Million USD | -926.352% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1499.58% |
| Pulmonx Corporation | 60.63 Million USD | 5.77% |
| iCAD, Inc. | 8 Million USD | -614.123% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -350.235% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -2991.98% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -40.075% |
| SI-BONE, Inc. | 61.05 Million USD | 6.41% |
| Semler Scientific, Inc. | 6.27 Million USD | -811.276% |
| Biotricity, Inc. | 35.91 Million USD | -59.07% |
| Cytosorbents Corporation | 29.98 Million USD | -90.549% |
| DexCom, Inc. | 4.19 Billion USD | 98.638% |
| ZimVie Inc. | 795.85 Million USD | 92.821% |
| Aethlon Medical, Inc. | 2.47 Million USD | -2204.236% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -377.811% |
| IceCure Medical Ltd | 4.24 Million USD | -1245.35% |
| Sight Sciences, Inc. | 46.43 Million USD | -23.045% |
| Insulet Corporation | 1.85 Billion USD | 96.921% |
| Profound Medical Corp. | 12.66 Million USD | -351.11% |
| electroCore, Inc. | 8.94 Million USD | -538.759% |
| Bioventus Inc. | 589.79 Million USD | 90.312% |
| InspireMD, Inc. | 8.14 Million USD | -601.756% |
| PAVmed Inc. | 57.13 Million USD | 0.0% |
| Nuwellis, Inc. | 6.78 Million USD | -742.729% |
| OrthoPediatrics Corp. | 72.56 Million USD | 21.257% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -377.811% |
| BrainsWay Ltd. | 15.31 Million USD | -273.103% |
| BIOLASE, Inc. | 35.34 Million USD | -61.641% |
| Beyond Air, Inc. | 29.77 Million USD | -91.896% |
| AxoGen, Inc. | 101.16 Million USD | 43.519% |
| Inari Medical, Inc. | 209.32 Million USD | 72.704% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -2513.994% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -3111.748% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.188% |
| Quanterix Corporation | 78.08 Million USD | 26.826% |
| Viveve Medical, Inc. | 10.84 Million USD | -426.754% |
| LivaNova PLC | 1.15 Billion USD | 95.04% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -224.014% |
| Varex Imaging Corporation | 668.6 Million USD | 91.454% |
| Vivani Medical, Inc. | 25.03 Million USD | -128.219% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1305.93% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1499.58% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1069.642% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 94.531% |
| TransMedics Group, Inc. | 568.84 Million USD | 89.956% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -242.507% |
| NeuroMetrix, Inc. | 1.33 Million USD | -4185.948% |
| Spectral AI, Inc. | 12.4 Million USD | -360.745% |
| Hyperfine, Inc. | 9.8 Million USD | -483.031% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 77.168% |
| Biomerica, Inc. | 2.66 Million USD | -2045.588% |
| Bone Biologics Corporation | 831.4 Thousand USD | -6772.367% |
| AVITA Medical, Inc. | 19.86 Million USD | -187.621% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -2794.943% |
| Silk Road Medical, Inc | 114.15 Million USD | 49.949% |